Page 1

Imugene Limited Appendix 4E Year ended 30 June 2021 Name of entity : ABN : Year ended : Previous period : Results for announcement to the market Revenue from ordinary activities Loss from ordinary activities after tax attributable to members Net loss for the period attributable to members 등등 Imugene Limited 99 009 179 551 30 June 2021 30 June 2020 Imugene Limited Appendix 4E 30 June 2021 - % to 75.6 % to 75.6 % to ( 18,455,363 ) ( 18,455,363 ) Distributions No dividends have been paid or declared by the company for the current financial year . No dividends were paid for the previous financial year . Explanation of results Please refer to the review of operations and activities on pages 2 to 9 for explanation of the results . Additional information supporting the Appendix 4E disclosure requirements can be found in the review of operations and activities , directors ' report and the financial statements for the year ended 30 June 2021 . Net tangible assets per security Net tangible asset backing ( per security ) Changes in controlled entities 2021 Cents 2020 Cents 0.60 0.66 There have been no changes in controlled entities during the year ended 30 June 2021 . Other information required by Listing Rule 4.3A a . Details of individual and total dividends or distributions and dividend or distribution payments : b . Details of any dividend or distribution reinvestment plans : N / A c . Details of associates and joint venture entities : N / A N / A d . Other information N / A